Abstract
AbstractCultivated oat (Avena sativa L.) is an allohexaploid (AACCDD, 2n = 6x = 42) thought to have been domesticated more than 3,000 years ago while growing as a weed in wheat, emmer and barley fields in Anatolia1,2. Oat has a low carbon footprint, substantial health benefits and the potential to replace animal-based food products. However, the lack of a fully annotated reference genome has hampered efforts to deconvolute its complex evolutionary history and functional gene dynamics. Here we present a high-quality reference genome of A. sativa and close relatives of its diploid (Avena longiglumis, AA, 2n = 14) and tetraploid (Avena insularis, CCDD, 2n = 4x = 28) progenitors. We reveal the mosaic structure of the oat genome, trace large-scale genomic reorganizations in the polyploidization history of oat and illustrate a breeding barrier associated with the genome architecture of oat. We showcase detailed analyses of gene families implicated in human health and nutrition, which adds to the evidence supporting oat safety in gluten-free diets, and we perform mapping-by-sequencing of an agronomic trait related to water-use efficiency. This resource for the Avena genus will help to leverage knowledge from other cereal genomes, improve understanding of basic oat biology and accelerate genomics-assisted breeding and reanalysis of quantitative trait studies.
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Vavilov, N. I. in Origin and Geography of Cultivated Plants (ed. Dorofeyev, V. F.) 22–135 (Cambridge Univ. Press, 1992).
2. Malzew, A. I. Wild and Cultivated Oats, Sectio Euavena Griseb. (Publ. of the All-Union Inst. of Appl. Botany and New Cultures under the Council of People's Commissars of the USSR, 1930).
3. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of a health claim related to oat β-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) no. 1924/2006. EFSA J. https://doi.org/10.2903/j.efsa.2010.1885 (2010).
4. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to β-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and ‘digestive function’ (ID 850) pursuant to Article 13(1) of Regulation (EC) no. 1924/2006). EFSA J. https://doi.org/10.2903/j.efsa.2011.2207 (2011).
5. Mathews, R., Kamil, A. & Chu, Y. Global review of heart health claims for oat β-glucan products. Nutr. Rev. 78, 78–97 (2020).
Cited by
105 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献